Rua Bioscience Limited — Board/Management Information 2022

Aug 8, 2022

ADMINISTRATIVE ANNOUNCEMENT

==> picture [133 x 77] intentionally omitted <==

FOR PUBLIC RELEASE NZX Limited Wellington

Monday, 8 August 2022

Announcement of Director Retirement

The Board of Directors of Rua Bioscience Limited (NZX: RUA) advises that Mr Martin Smith has decided to retire as an Independent Non-Executive Director. Martin’s retirement will be effective at the conclusion of the 2022 Annual General Meeting scheduled for October 12, 2022.

Martin joined the Board of Directors in 2018 and is currently the Chair of the Nominations and Remunerations Committee.

Rua’s Chair Mr Trevor Burt, on behalf of the Board, expresses his sincere appreciation of Martin’s significant contribution to the company during his five-year tenure. Mr Burt said that ‘it is quite a career milestone for Martin to join our founders when the business was at the conceptual stage, and to be a key part of the governance team who guided the business through to a NZX listing and readiness for export markets. We wish Martin all the best for his future.’

Martin Smith’s retirement is consistent with the Board’s succession plan and follows the recent appointment of Teresa Farac-Ciprian as an Independent Non-Executive Director. Teresa brings an exceptional background in commercialisation, innovation, marketing and business development – skills particularly relevant as the company nears export market entry.

ENDS

For more information please contact: Kerry Donovan Communications Manager, Rua Bioscience Ltd Kerry.donovan@ruabio.com +64 (0)21 128 7689

PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com